Cargando…
Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment
OBJECTIVE: Studying treatment duration for rifampicin-resistant and multidrug-resistant tuberculosis (MDR/RR-TB) using observational data is methodologically challenging. We aim to present a hypothesis generating approach to identify factors associated with shorter duration of treatment. STUDY DESIG...
Autores principales: | Winters, Nicholas, Schnitzer, Mireille E., Campbell, Jonathon R., Ripley, Susannah, Winston, Carla, Savic, Rada, Ahmad, Nafees, Bisson, Gregory, Dheda, Keertan, Esmail, Ali, Gegia, Medea, Monedero, Ignacio, Dalcolmo, Margareth Pretti, Rodrigues, Denise, Singla, Rupak, Yim, Jae-Joon, Menzies, Dick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553332/ https://www.ncbi.nlm.nih.gov/pubmed/37797071 http://dx.doi.org/10.1371/journal.pone.0292106 |
Ejemplares similares
-
Tuberculosis: where are we?
por: Mello, Fernanda Carvalho de Queiroz, et al.
Publicado: (2018) -
Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
por: Sabur, Natasha F., et al.
Publicado: (2017) -
Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019) -
Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
por: Silva, Denise Rossato, et al.
Publicado: (2021) -
Latent Tuberculosis Infection–associated Immunodiagnostic Test
Responses as Biomarkers of Incipient Tuberculosis: Fruitful or
Futile?
por: Dheda, Keertan, et al.
Publicado: (2020)